Researchers at the Cincinnati Children's Hospital Medical Center report in the journal 'Science Translational Medicine' that they have successfully developed and tested a new rapid blood test that measures five biomarkers and accurately predicts which patients have a low, medium or high risk of death by sepsis.
After decades of little or no progress, biomedical researchers are finally making progress in detecting and treating this life-threatening medical complication that sends a surge of pathogenic infection throughout the body.
Called 'PERSEVERE', the test allows doctors to detect and stratify sepsis in its early stages, just when the body is about to unleash a storm of bacterial infection, according to the study's principal investigator, Hector Wong, director of Medicine at Critical Care of Cincinnati Children's Hospital Medical Center.RELATED
By knowing which five proteins / genes make up the blood panel of five biomarkers in the trial, doctors should be able to begin medical interventions much earlier and more accurately.
The test allows doctors to choose the correct interventions for specific patients.